Displaying 1 - 1 of 1
| Active Ingredient | BETAHISTINE |
| Therapeutic Class | VASODILATING AGENTS |
| Indications | Vertigo, tinnitus and hearing loss associated with Mé•nière'sdisease. |
| Caution | Gastro-intestinal disturbances; headache; pruritus; rashes. Betahistine should be given with care to patients with asthma, peptic ulcer disease or a history pepticulcer disease. |
| Dose Range | Initially 16mg 3 times a day, maintenance 24-48mg daily. Dose preferably taken with food. |
| Drug Interactions | |
| Pregnancy | Avoid unless clearly necessary. |
| Breast Feeding | Use only if potential benefit outweighs risk. |